MedPath

Intervention study of cognitive behavioral therapy program for patients with substance use disorder and other mental disorders

Not Applicable
Conditions
Substance Use Disorders
Registration Number
JPRN-UMIN000012344
Lead Sponsor
Department of Psychiatry Showa University, School of Medicine
Brief Summary

Japanese Bulletin of Social Psychiatry 26:11-24,2017 The results revealed that these individuals had difficult backgrounds, including a high rate of never being married, a low level of education, unemployment, a history of narcotics use, and a history of crime. About 60 percent of the subjects had concurrent psychotic disorders with a combination of psychotic disorder and substance use disorder (PSCD group). Compared with non-psychotic substance use disorder patients (NPs-SUD group), those in the PSCD group were younger, unemployment, and tended to have a history of narcotics use and crime. A certain improvement partially effect was seen as a result of this program in PSCD group, with increases in the function of generalization, schedule for assessment of insight, effective for stopping the substance use. But self-rating scales was not seen improvement effect by row value self-efficacy scale. In addition to these interventions, the concurrent use of individual interventions to raise self-efficacy , other programs for psychopathic symptoms and/or to participate repetition is thought to be necessary for patients with concurrent psychotic disorders. In the future, more active implementation of simple programs for this type of concurrent disorder will be required at a greater number of designated hospitals for forced psychiatric treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who are inadequate for treatment judged by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath